SA50-0692 Screening compound: 5-[5-(2,4-difluorobenzenesulfonyl)-1-methyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-yl]-3-(2-methoxyethyl)-1,2,4-oxadiazole

SA50-0692 Screening compound: 5-[5-(2,4-difluorobenzenesulfonyl)-1-methyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-yl]-3-(2-methoxyethyl)-1,2,4-oxadiazole
SA50-0692 Screening compound: 5-[5-(2,4-difluorobenzenesulfonyl)-1-methyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-yl]-3-(2-methoxyethyl)-1,2,4-oxadiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound SA50-0692
5-[5-(2,4-difluorobenzenesulfonyl)-1-methyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-yl]-3-(2-methoxyethyl)-1,2,4-oxadiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SA50-0692

Molecular Formula

C17H17F2N5O4S (C17 H17 F2 N5 O4 S)

Compound Name

5-[5-(2,4-difluorobenzenesulfonyl)-1-methyl-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-yl]-3-(2-methoxyethyl)-1,2,4-oxadiazole

IUPAC name

5-[5-(24-difluorobenzenesulfonyl)-1-methyl-1H4H5H6H-pyrrolo[34-c]pyrazol-3-yl]-3-(2-methoxyethyl)-124-oxadiazole

SMILES

Cn(c(C1)c2CN1S(c(ccc(F)c1)c1F)(=O)=O)nc2-c1nc(CCOC)no1

InChI

InChI=1S/C17H17F2N5O4S/c1-23-13-9-24(29(25,26)14-4-3-10(18)7-12(14)19)8-11(13)16(21-23)17-20-15(22-28-17)5-6-27-2/h3-4,7H,5-6,8-9H2,1-2H3

InChI Key

IEQCNNIYCCAXOB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31972121

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

425.42

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.279

Distribution Coefficient, logD

1.279

Water Solubility, LogSw

-2.35

Polar Surface Area

87.939

Acid Dissociation Constant (pKa)

18.77

Base Dissociation Constant (pKb)

0.77

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.30

SA50-0692 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with SA50-0692 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SA50-0692?
Check Price and Availability of SA50-0692, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SA50-0692 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SA50-0692
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SA50-0692
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SA50-0692 available by request